Compositions and methods for expression of GLP-1 receptor agonists

TW202641975APending Publication Date: 2026-10-16REPLICATE BIOSCIENCE INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115100881
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-10
Filing Date
2026-01-09
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080904_001
    Figure TWG2TA001080904_001
  • Figure TWG2TA001080904_002
    Figure TWG2TA001080904_002
  • Figure TWG2TA001080904_003
    Figure TWG2TA001080904_003
Patent Text Reader

Abstract

receptor (GLP-1R) agonists, as a monogenic or multigenic along with GPCR agonists, GIPR agonists, and GCGR agonists, pharmaceutical compositions and recombinant cells containing the same, as well as the use of such srRNA molecules, recombinant cells, and compositions for activating GLP-1R signaling in a subject. Also provided are methods for preventing and / or treating various health conditions associated with GLP-1R signaling.
Need to check novelty before this filing date? Find Prior Art